The results indicated that expression level of STC2 was significantly correlated with MMRs in almost all cancers except BLCA, cholangiocarcinoma (CHOL), DLBC, glioblastoma multiforme (GBM), KICH, LAML, and SARC. This evidence concerns the gene STC2 and bladder transitional cell carcinoma.